TABLE 1

Characteristics of the 11 Patients

Patient no.	Age (y)	Initial staging (TNM classification)	Histology	Estrogen receptor status	Progesterone receptor status	Prior adjuvant therapy
1	34	pT2 pN0 G3	Ductal	Negative	Positive	CMF
2	53	pT2 pN1 G2	Lobular	NA	NA	EC, tamoxifen
3	55	pT4 pNx G3	Ductal	Positive	Positive	None
4	60	pT4 pNx G3	Ductal	Positive	Positive	None
5	58	pT2 pN1 G3	Ductal	Negative	Negative	CMF
6	44	pT3 pN0 Gx	Ductal	Negative	Negative	CMF
7	68	pT1 pN0 G2	Ductal	Negative	Positive	Tamoxifen
8	49	pT2 pN0 G3	Ductal	Negative	Negative	None
9	41	pT2 pN0 G3	Ductal	Positive	Positive	CMF, tamoxifen
10	45	pT2 pN1 G3	Ductal	Positive	Negative	None
11	30	pT2 pN0 G3	Ductal	Positive	Positive	CMF, tamoxifen

CMF = cyclophosphamide, methotrexate, and fluorouracil; NA = not applicable; EC = epirubicin/cyclophosphamide.